WO2007076467A3 - Use of anecortave acetate as an adjunct during filtration bleb surgery - Google Patents
Use of anecortave acetate as an adjunct during filtration bleb surgery Download PDFInfo
- Publication number
- WO2007076467A3 WO2007076467A3 PCT/US2006/062541 US2006062541W WO2007076467A3 WO 2007076467 A3 WO2007076467 A3 WO 2007076467A3 US 2006062541 W US2006062541 W US 2006062541W WO 2007076467 A3 WO2007076467 A3 WO 2007076467A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- anecortave acetate
- during filtration
- surgery
- filtration bleb
- adjunct during
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Prostheses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06846780A EP1962857A2 (en) | 2005-12-23 | 2006-12-22 | Use of anecortave acetate as an adjunct during filtration bleb surgery |
JP2008547781A JP2009521511A (en) | 2005-12-23 | 2006-12-22 | Use of anecoltab acetate as an adjunct during follicular surgery |
CA002631838A CA2631838A1 (en) | 2005-12-23 | 2006-12-22 | Use of anecortave acetate as an adjunct during filtration bleb surgery |
AU2006330531A AU2006330531A1 (en) | 2005-12-23 | 2006-12-22 | Use of anecortave acetate as an adjunct during filtration bleb surgery |
BRPI0620411-2A BRPI0620411A2 (en) | 2005-12-23 | 2006-12-22 | use of anecortave acetate as a supplement during hyperfunctioning bag filtration surgery |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75351105P | 2005-12-23 | 2005-12-23 | |
US60/753,511 | 2005-12-23 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007076467A2 WO2007076467A2 (en) | 2007-07-05 |
WO2007076467A3 true WO2007076467A3 (en) | 2007-08-16 |
Family
ID=38067101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/062541 WO2007076467A2 (en) | 2005-12-23 | 2006-12-22 | Use of anecortave acetate as an adjunct during filtration bleb surgery |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1962857A2 (en) |
JP (1) | JP2009521511A (en) |
KR (1) | KR20080078042A (en) |
CN (1) | CN101346145A (en) |
AU (1) | AU2006330531A1 (en) |
BR (1) | BRPI0620411A2 (en) |
CA (1) | CA2631838A1 (en) |
WO (1) | WO2007076467A2 (en) |
ZA (1) | ZA200805052B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080125406A1 (en) * | 2005-10-14 | 2008-05-29 | Robin Alan L | Method for Treating Primary and Secondary Forms of Glaucoma |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997041867A1 (en) * | 1996-05-09 | 1997-11-13 | Alcon Laboratories, Inc. | Use of steroid compounds to prevent non-cancerous tissue growth |
WO1997041852A1 (en) * | 1996-05-09 | 1997-11-13 | Alcon Laboratories, Inc. | Angiostatic compounds |
US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
US6489305B1 (en) * | 1998-05-08 | 2002-12-03 | Canji, Inc. | Methods and compositions for the treatment of ocular diseases |
WO2005102297A2 (en) * | 2004-04-23 | 2005-11-03 | Alcon, Inc. | Angiostatic agents for controlling choroidal neovascularisation after ocular surgery of trauma |
-
2006
- 2006-12-22 CN CNA2006800489261A patent/CN101346145A/en active Pending
- 2006-12-22 AU AU2006330531A patent/AU2006330531A1/en not_active Abandoned
- 2006-12-22 JP JP2008547781A patent/JP2009521511A/en not_active Withdrawn
- 2006-12-22 KR KR1020087016572A patent/KR20080078042A/en not_active Application Discontinuation
- 2006-12-22 EP EP06846780A patent/EP1962857A2/en not_active Withdrawn
- 2006-12-22 BR BRPI0620411-2A patent/BRPI0620411A2/en not_active Application Discontinuation
- 2006-12-22 ZA ZA200805052A patent/ZA200805052B/en unknown
- 2006-12-22 WO PCT/US2006/062541 patent/WO2007076467A2/en active Application Filing
- 2006-12-22 CA CA002631838A patent/CA2631838A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997041867A1 (en) * | 1996-05-09 | 1997-11-13 | Alcon Laboratories, Inc. | Use of steroid compounds to prevent non-cancerous tissue growth |
WO1997041852A1 (en) * | 1996-05-09 | 1997-11-13 | Alcon Laboratories, Inc. | Angiostatic compounds |
US6011023A (en) * | 1997-08-27 | 2000-01-04 | Alcon Laboratories, Inc. | Angiostatic steroids |
US6489305B1 (en) * | 1998-05-08 | 2002-12-03 | Canji, Inc. | Methods and compositions for the treatment of ocular diseases |
WO2005102297A2 (en) * | 2004-04-23 | 2005-11-03 | Alcon, Inc. | Angiostatic agents for controlling choroidal neovascularisation after ocular surgery of trauma |
Non-Patent Citations (2)
Title |
---|
SHAUNAK SUNIL ET AL: "Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation", NATURE BIOTECHNOLOGY, vol. 22, no. 8, August 2004 (2004-08-01), pages 977 - 984, XP002436146, ISSN: 1087-0156 * |
WONG JAMIE ET AL: "Modulation of human fibroblast activity by selected angiogenesis inhibitors", EXPERIMENTAL EYE RESEARCH, vol. 58, no. 4, 1994, pages 439 - 451, XP002436145, ISSN: 0014-4835 * |
Also Published As
Publication number | Publication date |
---|---|
BRPI0620411A2 (en) | 2011-11-08 |
ZA200805052B (en) | 2009-10-28 |
AU2006330531A1 (en) | 2007-07-05 |
EP1962857A2 (en) | 2008-09-03 |
WO2007076467A2 (en) | 2007-07-05 |
KR20080078042A (en) | 2008-08-26 |
JP2009521511A (en) | 2009-06-04 |
CA2631838A1 (en) | 2007-07-05 |
CN101346145A (en) | 2009-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007136759A3 (en) | Method for the treatment and prevention of ocular disorders | |
WO2005068421A8 (en) | Prostaglandin nitrooxyderivatives | |
WO2006060618A3 (en) | Topical nepafenac formulations | |
WO2007020213A3 (en) | Thiazolyl piperidine derivatives useful as h3 receptor modulators | |
IS7215A (en) | Methods for the treatment of ocular diseases of the eye | |
AU2003297684A1 (en) | Compositions, targets, methods and devices for the therapy of ocular and periocular disorders | |
WO2005080352A3 (en) | Quinazoline derivatives and therapeutic use thereof | |
WO2006091567A3 (en) | Hydroxyalkyl substituted imidazoquinoline compounds and methods | |
WO2004075864A3 (en) | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof | |
WO2006086562A3 (en) | Phenylazetidinone derivatives | |
WO2005046603A3 (en) | Pyridine compounds | |
IS7822A (en) | Eye Compositions for the Treatment of Ocular Hypertension | |
AU2003223224A8 (en) | Compositions and methods for the treatment of glaucoma and ocular hypertension | |
WO2006044425A3 (en) | Ophthalmic compositions for treating ocular hypertension | |
EP1664011A4 (en) | Ophthalmic compositions for treating ocular hypertension | |
NZ597866A (en) | Therapeutic lactams | |
WO2007131907A3 (en) | 1h-indol-5-yl-piperazin-1-yl-methanone derivatives | |
CL2007003836A1 (en) | USE OF COMPOUNDS DERIVED FROM ISOSORBIDE IN THE PREVENTION AND / OR TREATMENT OF OPHTHALMOLOGICAL DISEASES MEDIATED BY OCULAR HYPERTENSION, SUCH AS GLAUCOMA. | |
WO2004075840A3 (en) | Selective non-steroidal glucocorticoid receptor modulators | |
WO2004108673A3 (en) | Inhibitors of papilloma virus | |
EP1581503A4 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2004093805A3 (en) | Selective spirocyclic glucocorticoid receptor modulators | |
EP1771170A4 (en) | Ophthalmic compositions for treating ocular hypertension | |
WO2007134085A3 (en) | Isothiazolidines useful in the treatment of ocular hypertensive conditions | |
AU2003241398A1 (en) | Methods of treatment of glaucoma and other conditions mediated by nos-2 expression via inhibition of the egfr pathway |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200680048926.1 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2631838 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006330531 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2008/007884 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006846780 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2008547781 Country of ref document: JP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2006330531 Country of ref document: AU Date of ref document: 20061222 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020087016572 Country of ref document: KR |
|
ENP | Entry into the national phase |
Ref document number: PI0620411 Country of ref document: BR Kind code of ref document: A2 Effective date: 20080623 |